Alexey Ulasov
Alexey Ulasov
Institute of Gene Biology, Russian Academy of Sciences
Verified email at
Cited by
Cited by
Targeted intracellular delivery of antibodies: the state of the art
TA Slastnikova, AV Ulasov, AA Rosenkranz, AS Sobolev
Frontiers in pharmacology 9, 1208, 2018
Properties of PEI-based polyplex nanoparticles that correlate with their transfection efficacy
AV Ulasov, YV Khramtsov, GA Trusov, AA Rosenkranz, ED Sverdlov, ...
Molecular Therapy 19 (1), 103-112, 2011
Subcellular trafficking and transfection efficacy of polyethylenimine–polyethylene glycol polyplex nanoparticles with a ligand to melanocortin receptor-1
MO Durymanov, EA Beletkaia, AV Ulasov, YV Khramtsov, GA Trusov, ...
Journal of controlled release 163 (2), 211-219, 2012
Antitumor Activity of Auger Electron Emitter 111In Delivered by Modular Nanotransporter for Treatment of Bladder Cancer With EGFR Overexpression
AA Rosenkranz, TA Slastnikova, TA Karmakova, MS Vorontsova, ...
Frontiers in pharmacology 9, 1331, 2018
Nrf2/Keap1/ARE signaling: Towards specific regulation
AV Ulasov, AA Rosenkranz, GP Georgiev, AS Sobolev
Life Sciences, 120111, 2021
Preparation, cytotoxicity, and in vivo antitumor efficacy of 111In-labeled modular nanotransporters
TA Slastnikova, AA Rosenkranz, NB Morozova, MS Vorontsova, ...
International journal of nanomedicine 12, 395, 2017
Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer
IV Alekseenko, EV Snezhkov, IP Chernov, VV Pleshkan, VK Potapov, ...
Journal of translational medicine 13 (1), 1-16, 2015
Transcription factors: Time to deliver
AV Ulasov, AA Rosenkranz, AS Sobolev
Journal of Controlled Release 269, 24-35, 2018
Microdistribution of MC1R-targeted polyplexes in murine melanoma tumor tissue
MO Durymanov, TA Slastnikova, AI Kuzmich, YV Khramtsov, AV Ulasov, ...
Biomaterials 34 (38), 10209-10216, 2013
Use of intracellular transport processes for targeted drug delivery into a specified cellular compartment
AA Rosenkranz, AV Ulasov, TA Slastnikova, YV Khramtsov, AS Sobolev
Biochemistry (Moscow) 79 (9), 928-946, 2014
Targeted Delivery of 111In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody
TS Karyagina, AV Ulasov, TA Slastnikova, AA Rosenkranz, TN Lupanova, ...
Frontiers in Pharmacology 11, 176, 2020
Investigation of transport and unpacking mechanisms of polyplexes for transfection efficacy on different cell lines
GA Trusov, AV Ulasov, EA Beletkaia, YV Khramtsov, MO Durymanov, ...
Doklady. Biochemistry and biophysics 437 (1), 77, 2011
Low-resolution structures of modular nanotransporters shed light on their functional activity
YV Khramtsov, AD Vlasova, AV Vlasov, AA Rosenkranz, AV Ulasov, ...
Acta Crystallographica Section D: Structural Biology 76 (12), 1270-1279, 2020
Study of biodistribution of the modular nanotransporters after systemic administration in murine cloudman S91 melanoma model
YV Khramtsov, AV Ulasov, AA Rosenkranz, GP Georgiev, AS Sobolev
Doklady Biochemistry and Biophysics 478 (1), 55-57, 2018
Characterization of new modular nanotransporters with albumin-binding domain
YV Khramtsov, AV Ulasov, AD Tsvetkova, AA Rosenkranz, GP Georgiev, ...
Doklady Biochemistry and Biophysics 472 (1), 81-83, 2017
Targeted intracellular delivery of antibodies: the state of the art. Front Pharmacol. 2018
TA Slastnikova, AV Ulasov, AA Rosenkranz
MNT optimization for intracellular delivery of antibody fragments
AV Ulasov, YV Khramtsov, TN Lupanova, AD Tsvetkova, AA Rosenkranz, ...
Doklady Biochemistry and Biophysics 479 (1), 62-65, 2018
Modular nanotransporter with P21 fragment inhibits DNA repair after bleomycin treatment
TR Kamaletdinova, AA Rosenkranz, AV Ulasov, YV Khramtsov, ...
Doklady Biochemistry and Biophysics 479 (1), 95-97, 2018
New recombinant carriers binding specifically to the epidermal growth factor receptor
TS Karyagina, AV Ulasov, AA Rosenkranz, TA Slastnikova, YV Khramtsov, ...
Doklady Biochemistry and Biophysics 490 (1), 22-24, 2020
Among Antibody-Like Molecules, Monobodies, Able to Interact with Nucleocapsid Protein of SARS-CoV Virus, There Are Monobodies with High Affinity to Nucleocapsid Protein of SARS …
YV Khramtsov, AV Ulasov, TN Lupanova, GP Georgiev, AS Sobolev
Doklady Biochemistry and Biophysics 503 (1), 90-92, 2022
The system can't perform the operation now. Try again later.
Articles 1–20